Search Results

Jürgen Wess and Liu Liu for their study on A novel function of the M2 muscarinic receptor Drs.

GPCR Summit 2022 is less than a month away!

February 2022 "Switzerland Today, InterAx Biotech is pleased to announce that Carola Weiss has joined Carola Weiss is a Senior Executive with more than 20 years of international experience in the biopharmaceutical Carola Weiss’ professional career brings deep expertise in business development, marketing & sales, licensing

Jurgen Wess’s lab at the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) - NIH,

Diagnose the mess → where your growth stalls. 2. What they are less prepared for is how much this uncertainty tests the team. Survival depends less on science and more on whether clarity scales with complexity.

Juergen Wess - Postdoc and Group leader in Aventis, now Sanofi, Frankfurt, Germany - Head of in vitro